# Single-centre Study to Investigate Safety and Efficacy of Tri-Solfen in Wound Debridement

> **NCT03865147** · PHASE2 · UNKNOWN · sponsor: **Medical Ethics UK Ltd** · enrollment: 90 (estimated)

## Conditions studied

- Wounds Injuries
- Anesthesia, Local

## Interventions

- **DRUG:** Tri-Solfen Gel (Lidocaine HCl, Bupivacaine HCl, Adrenaline Acid Tartrate /Cetrimide)
- **DRUG:** EMLA cream
- **DRUG:** Post Operative Analgesia (Paracetamol, Ibuprofen)

## Key facts

- **NCT ID:** NCT03865147
- **Lead sponsor:** Medical Ethics UK Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-01-15
- **Primary completion:** 2019-07-30
- **Final completion:** 2019-07-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2019-03-06

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03865147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03865147, "Single-centre Study to Investigate Safety and Efficacy of Tri-Solfen in Wound Debridement". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03865147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*